A reminder that on 6th March there will be two BVHG meetings running in parallel, the main meeting and the inaugural BVHG Maternal & Paediatric Sub-Group meeting. Online booking is open, we hope that you join us for what will be a fantastic event.

Main Meeting: Newer HCV regimens - why, how and when...
(10.00-16.15)
The first BVHG meeting of the year will address EAPs, modelling, commissioning, accessing and engaging patients.  An international speaker will provide the European perspective also.

Sub-group Meeting: Pregnancy - HBV Research & HCV Screening
(11.30 - 15.10)
You may attend sessions of the main BVHG meeting before and after this meeting.

Registration Fee
All BASL Members - Free* (a £50 refundable deposit applies)
Non-members £45

The meeting will also feature a satellite session by Gilead during the second half of the lunch break to complement the programme. More details on this satellite meeting will be available in due course.

Further information & booking
>Go to the event page for further information and to book online.

Please forward details to your colleagues who may be interested in attending.

>19th Advanced Gastroenterology & Hepatology Course 2015
05-06 February, RCP Edinburgh

>Nottingham Postgraduate Course for the Gastro SCE (2015)
09-10 February, Nottingham

>Endolive UK 2015
12-13 March 2015, Birmingham

>Liver Course 2015
21-22 May, Birmingham

To be hosted at the Centre for Professional Development, Medical School, University of Birmingham, for trainees, consultants, nurses and allied health professionals who work locally, regionally and nationally. 

The programme covers practical and pressing issues in the management of advanced liver disease with expert speakers from around the country.

Further details can be found at www.birmingham.ac.uk/liver2015

NHS England have confirmed that the HCV Early Access Program (providing treatment with sofosbuvir and ledipasvir or daclatasvir for patients with advanced disease) is still open to patients fulfilling the criteria (for details see http://www.england.nhs.uk/wp-content/uploads/2014/04/sofosbuvir-pol-stat.pdf).  The HCV Clinical Advisory Group is working with NHS England to ensure that all people with cirrhosis have early access to therapy with the emerging all oral antiviral agents; an announcement is expected soon.

BASL is now a registered stakeholder for the following NICE consultations:

• Neonatal Jaundice
• Alcohol use disorders: Diagnosis & clinical management of alcohol-related physical complications (surveillance)

This is in addition to the other topics for which BASL is already a stakeholder:

• Alcohol: preventing harmful alcohol use in the community
• Assessment and Management of Cirrhosis
• Liver disease (non-alcoholic fatty [NAFLD])
• Hepatitis B (Quality Standard)
• Sickle Cell Crisis (Quality Standard)

The BASL Schools of Hepatology will again be running in 2015, along with other mono-thematic events.  Further information will follow once dates have been confirmed.

Please forward this information to Nurses in your Trust, the bursaries are available to all UK hepatology nurses

Don't miss your chance to apply for funding to support your travel to EASL 2015.  BASL are administering 15 nurse bursaries of £1250 each to support attendance at EASL 2015 (22-26 April in Vienna).  The bursaries are offered by Janssen-Cilag Ltd.

Please complete and return your application form before the deadline of Friday 13th February 2015.

>Click here for further information

Do you know of any members who are not receiving the member communications?  It may be that their email address has changed and we are not aware.  Please ask them to contact jane.douthwaite@execbs.com at the BASL Secretariat and we will update their record. Thank you!